McMillan Shakespeare Ltd (ASX: MMS) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
McMillan Shakespeare Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
McMillan Shakespeare Ltd (ASX: MMS)
Latest News
Share Market News
ALL ORDINARIES finishes higher Tuesday: 8 ASX shares you missed
⏸️ Investing
Lead fund managers share 5 stock ideas
Share Gainers
Why these are the top 3 best performing ASX stocks in August
Share Gainers
These were the best-performing shares on the ASX 200 last week
Share Gainers
ALL ORDINARIES finishes lower Wednesday: 8 shares you missed
⏸️ Investing
Results: McMillan Shakespeare shares soar 17% on earnings to lead ASX
Share Gainers
Why Bapcor, Kogan, McMillan Shakespeare, & WiseTech Global stormed higher today
Share Market News
ASX 200 lunch time report: a2 Milk, Domino's, & Nearmap lower
Share Market News
Smartgroup shares soar on smashed expectations
Share Gainers
Is the Eclipx Group share price in the buy zone yet?
Share Fallers
These were the worst-performing shares on the ASX 200 last week
Share Gainers
ALL ORDINARIES finishes higher Tuesday: 8 shares you missed
Frequently Asked Questions
-
Yes, McMillan Shakespeare historically pays two fully franked dividends a year.
-
McMillan Shakespeare generally pays its shareholder dividends in March and September.
-
McMillan Shakespeare Ltd list on the ASX on 2 July 2018.
Dividend Payment History Data provided by Morningstar.
Ex-Date | Amount | Franking | Type | Payable |
---|---|---|---|---|
07 Mar 2024 | $0.7600 | 100.00% | Interim | 22 Mar 2024 |
07 Sep 2023 | $0.6600 | 100.00% | Final | 22 Sep 2023 |
09 Mar 2023 | $0.5800 | 100.00% | Final | 24 Mar 2023 |
26 Oct 2022 | $0.7400 | 100.00% | Final | 10 Nov 2022 |
10 Mar 2022 | $0.3400 | 100.00% | Interim | 25 Mar 2022 |
09 Sep 2021 | $0.3110 | 100.00% | Final | 24 Sep 2021 |
11 Mar 2021 | $0.3020 | 100.00% | Interim | 26 Mar 2021 |
05 Mar 2020 | $0.3400 | 100.00% | Interim | 20 Mar 2020 |
28 Aug 2019 | $0.4000 | 100.00% | Final | 11 Sep 2019 |
07 Mar 2019 | $0.3400 | 100.00% | Interim | 22 Mar 2019 |
13 Sep 2018 | $0.4000 | 100.00% | Final | 28 Sep 2018 |
15 Mar 2018 | $0.3300 | 100.00% | Interim | 29 Mar 2018 |
28 Sep 2017 | $0.0000 | 100.00% | Final | 13 Oct 2017 |
30 Mar 2017 | $0.3100 | 100.00% | Interim | 13 Apr 2017 |
29 Sep 2016 | $0.3400 | 100.00% | Final | 14 Oct 2016 |
31 Mar 2016 | $0.2900 | 100.00% | Interim | 15 Apr 2016 |
16 Sep 2010 | $0.1400 | 100.00% | Final | 15 Oct 2010 |
08 Mar 2006 | $0.0250 | 100.00% | Interim | 29 Mar 2006 |
18 Aug 2005 | $0.0240 | 100.00% | Final | 16 Sep 2005 |
MMS ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About McMillan Shakespeare Ltd
McMillan Shakespeare Ltd (ASX: MMS) is an employee benefits provider. Its services include salary packaging, novated leasing, disability plan management and support coordination, asset management, and related financial products and services.
The company's asset management businesses provide motor vehicle leasing and fleet management services, as well as fleet and consumer financing.
McMillan Shakespeare consists of more than 20 subsidiaries, the majority incorporated in Australia but also in New Zealand and the United Kingdom.
MMS Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
26 Apr 2024 | $18.85 | $-0.32 | -1.67% | 191,659 | $18.94 | $19.04 | $18.74 |
24 Apr 2024 | $19.17 | $-0.01 | -0.05% | 202,246 | $19.16 | $19.23 | $18.86 |
23 Apr 2024 | $19.18 | $-0.44 | -2.24% | 136,528 | $19.62 | $19.66 | $19.16 |
22 Apr 2024 | $19.62 | $0.18 | 0.93% | 147,352 | $19.50 | $19.67 | $19.13 |
19 Apr 2024 | $19.44 | $-0.11 | -0.56% | 103,134 | $19.56 | $19.65 | $19.25 |
18 Apr 2024 | $19.55 | $0.06 | 0.31% | 166,487 | $19.46 | $19.80 | $19.46 |
17 Apr 2024 | $19.49 | $0.33 | 1.72% | 123,261 | $19.30 | $19.53 | $19.20 |
16 Apr 2024 | $19.16 | $-0.27 | -1.39% | 125,562 | $19.37 | $19.62 | $19.12 |
15 Apr 2024 | $19.43 | $-0.41 | -2.07% | 142,928 | $19.85 | $19.85 | $19.42 |
12 Apr 2024 | $19.84 | $0.46 | 2.37% | 209,388 | $19.30 | $19.84 | $19.30 |
11 Apr 2024 | $19.38 | $-0.01 | -0.05% | 138,146 | $19.23 | $19.51 | $19.10 |
10 Apr 2024 | $19.39 | $0.39 | 2.05% | 128,411 | $19.21 | $19.45 | $19.09 |
09 Apr 2024 | $19.00 | $-0.11 | -0.58% | 155,578 | $19.25 | $19.33 | $19.00 |
08 Apr 2024 | $19.11 | $-0.26 | -1.34% | 129,808 | $19.37 | $19.48 | $19.07 |
05 Apr 2024 | $19.37 | $0.25 | 1.31% | 133,658 | $19.15 | $19.50 | $19.09 |
04 Apr 2024 | $19.12 | $-0.07 | -0.36% | 144,994 | $19.11 | $19.35 | $19.10 |
03 Apr 2024 | $19.19 | $-0.10 | -0.52% | 157,118 | $19.29 | $19.38 | $19.05 |
02 Apr 2024 | $19.29 | $-0.34 | -1.73% | 251,309 | $19.31 | $19.44 | $19.13 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
17 Nov 2023 | Robert (Rob) De Luca | Issued | 58,970 | $1,043,179 |
Issue of securities. 162,498 Performance Rights
|
24 Aug 2023 | Kathryn Parsons | Buy | 500 | $9,650 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Bruce John Akhurst | Non-Executive Director | Apr 2021 |
Mr Akhurst is currently the Chairman of Tabcorp Holdings Limited and a member of the Audit Committee, Technology Committee, Nomination Committee, People and Remuneration Committee and Interim Chair of the Risk, Compliance and Sustainability Committee. Mr Akhurst is also Chair of the Peter McCallum Cancer Foundation and Council Member of RMIT University chairing the Infrastructure and Information Technology Committee.
|
Mr John G Bennetts | Non-Executive Director | Dec 2003 |
Mr Bennetts is an experienced investor and has been the founder and director of a number of Australian companies. He owns businesses in varied industries including technology and finance. Mr Bennetts is a Non-Executive Director of Sacred Heart Mission. He was a founder of Cellestis Limited and private equity investment firm, Mooroolbark Investments Pty Limited (M-Group). He has also provided corporate advisory services to a range of companies in Australia and Asia.
|
Mr Ross Chessari | Non-Executive Director | Dec 2003 |
Mr Chessari is a founder and director of the investment manager, SciVentures Investments Pty Limited (SciVentures). Prior to founding SciVentures, Mr Chessari was the Managing Director of ANZ Asset Management and the General Manager of ANZ Trustees.
|
Ms Helen Kurincic | Non-Executive DirectorNon-Executive Chairman | Sep 2018 |
Ms Kurincic is Non-Executive Chair of Integral Diagnostics Limited, Non-Executive Director of Estia Health Limited, HBF Health Limited and the Victorian Clinical Genetics Service. Formerly, Ms Kurincic was the Chief Operating Officer and Director of Genesis Care from its inception, creating and developing the first and radiation oncology and cardiology business across Australia. She has also formerly held Board roles across the publicly listed, private, not-for-profit and government sectors as well as being the former CEO of Benetas and Heart Care Victoria. Ms Kurincic is a Fellow of the Australian Institute of Company Directors and Governance Institute of Australia. She has also completed the Cambridge Institute for Sustainability Leadership NED Programme.
|
Ms Arlene May Tansey | Non-Executive Director | Nov 2022 |
Ms Tansey is a Non-Executive Director of TPG Telecom, Aristocrat Leisure Limited, Wisetech Global, Lend Lease Real Estate Investments Limited, the Australian Institute of Company Directors (NSW Division Council) and the Australian National Maritime Museum. Arlene is also a member of the Board of Advice of the University of Sydney Business School. Before becoming a non-executive Director, Arlene worked in commercial and investment banking in Australia (ANZ Banking Group and Macquarie Bank) and in investment banking and law in the United States.
|
Mr Robert (Rob) De Luca | Chief Executive OfficerManaging Director | May 2022 |
Mr De Luca joined MMS in May 2022 and has over 20 years experience in Financial Services, Wealth Management, Disability and Healthcare, including roles as Managing Director of Bankwest, CEO of the National Disability Insurance Agency (NDIA) and most recently as CEO of Zenitas Healthcare.
|
Ms Kathryn Maree Parsons | Non-Executive Director | May 2020 |
Ms Parsons is currently a Non-Executive Director of Tassal Group Limited and a NonExecutive Director of Shape Australia Corporation Limited. Formerly, Ms Parsons was an audit partner at Ernst & Young where she spent time as a partner in the firm's US, UK and Australian practices. In addition to her audit client responsibilities she was part of the firm's Oceania Assurance Leadership team as the Professional Practice Director with responsibility for assurance quality and risk management in the region.
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
HSBC Custody Nominees (Aust) Ltd | 17,717,211 | 25.44% |
JP Morgan Nominees Australia Limited | 9,889,906 | 14.20% |
Citicorp Nominees Limited | 8,878,618 | 12.75% |
Chessari Holdings Pty Limited | 6,050,941 | 8.69% |
AP Group Pty Limited | 3,976,229 | 5.71% |
National Nominees Limited | 3,408,305 | 4.89% |
Asia Pac Technology Pty Ltd | 3,068,025 | 4.41% |
UBS Nominees Pty Limited | 1,971,968 | 2.83% |
Ann Leslie Ryan | 1,008,418 | 1.45% |
BNP Paribas Nom Pty Limited <DRP> | 756,878 | 1.09% |
NewEconomy com AU Nominees Pty Limited | 327,205 | 0.47% |
MOHL Invest Pty Ltd <MOHL Super Fund A/c> | 310,000 | 0.45% |
Citicorp Nominees Pty Ltd <Colonial First State Inv A/c> | 237,391 | 0.34% |
Warbont Nominees Pty Ltd <Unpaid Entrepot A/c> | 224,539 | 0.32% |
BNP Paribas Noms Pty Ltd <Global markets DRP> | 174,569 | 0.25% |
AFICO Pty Ltd | 130,000 | 0.19% |
Mod Enterprises Pty Ltd | 129,619 | 0.19% |
WAL Assets Pty Ltd <The LA Wilson Property A/c> | 114,795 | 0.16% |
Birdseye No. Management Pty Ltd <Birdseye Super No. Fund A/c> | 110,000 | 0.16% |
BNP Paribas Nominees Pty Ltd Hub4 Custodial Serv Ltd <DRP A/c> | 99,864 | 0.14% |